Back

dr. J.F. Swart

dr. J.F. Swart

Assistant Professor - medical
dr. J.F. Swart
  • Immunology patient care

Biography

Biography

Joost Swart is a board certified paediatrician immunologist & rheumatologist. After receiving his Medical Degree (cum laude/ with Honour) from the University of Groningen in 1999, he finished his training as a paediatrician at the VU Medical Center in Amsterdam in 2006. His fellowship paediatric rheumatology-immunology was completed in 2008 in Utrecht. He worked as a paediatric rheumatologist for 3 years in both Reade and the VUmc in Amsterdam. In 2011 he came to work in the largest Dutch group of Pediatric Rheumatology / Immunology based in Utrecht. He is currently doing a Master in Epidemiology at Utrecht University.

His research (and that of his PhD-students) focuses on comparative effectiveness and safety of drugs, treatment-strategies and eHealth in juvenile idiopathic arthritis (JIA). He also analysed the effects of mesenchymal stem cells in JIA-patients. Furthermore he is researcher and member of the Steering Committee of the international Pharmacovigilance database Pharmachild (over 9000 JIA-patients who have contributed their clinical data and thousands of blood and synovial samples) and is co-P.I. of the UCAN CAN-DU project (JIA project involving all academic paediatric rheumatology centers in the Netherlands and Canada). https://www.ucancandu.com/

He is (co-)author on more than 60 scientific articles in peer-reviewed journals, mostly related to JIA. He is (co-)applicant on multiple successful research grants (e.g. UCAN CAN-DU. Real-life integration of innovative precision medicine strategies into care provision will forever transform the care of children with arthritis in our countries and beyond. Canadian Institutes of Health Research/ The Netherlands Organisation for Health Research and Development [ZonMw]/ Dutch Arthritis Foundation funded  €5,500,000).

He is council member of the Dutch Association for Paediatric Rheumatology, council member of the Pediatric Rheumatology International Trial Organization and chair of the Pharmacovigilance and Targeted Therapies Working Party of ERN-RITA. He is member of the Dutch Pediatric Association, Dutch Rheumatology Association, Paediatric Rheumatology European Society, and the Dutch Association against Quackery.

He educates students in both the CRU and Summa medical curricula in Utrecht. He trains interns, residents and fellows in paediatrics and rheumatology in UMC Utrecht. He is a certified instructor on the APLS-course from the Advance Life Support Group.

Side Activities

-Chair of Pharmacovigilance Working Party, European Reference Network, Rare Immunodeficiencies, AutoImmune and AutoInflammatory Diseases (ERN RITA)

-Co-chair of Clinical Guidelines Working Party, ERN RITA

-Council Member for the Paediatric Rheumatology International Trials Organisation (PRINTO)

Board member of the Dutch Pediatric Rheumatology Association

-National coordinator Pediatric Rheumatology International Trials Organization (Printo)

-Member of the European Medicines Agency (EMA) Working Party with Healthcare Professionals on behalf of European League against Rheumatism (EULAR)

-Member of JIA Working Group of Outcome Measures in Rheumatology (OMERACT)

-Member of the SHARE initiative European consensus-based recommendations for

the diagnosis and treatment of JIA

-Member of Digital Health Working Party of Dutch Rheumatology Association (NVR)

-Member of Steering Committee of UCAN CAN-DU

-Member of Steering Committee of PharmaChild

-Member of Data Safety Monitoring Board STARS Trial (PRINTO study with PI: Dr Consolaro)

-Member of Digital Health Working Party of Dutch Rheumatology Association (NVR)

-Utrecht representative of Dutch Paediatric Clinical Trial Network (Pedmed-NL) 

 

Fellowship and Awards

2015                            “The Addition of one or more Biologics to Methotrexate in Children with JIA increases the Incidence of

                                   Infections and Serious Adverse Events. The 5882 Pharmachild Cohort.” Selected as Top 6 of Clinical

                                   Science Abstracts chosen from 4323 Abstracts EULAR Congress Rome

2010                            “Mesenchymal Stem Cell Therapy has significant Clinical and Histopathological Effect in Proteoglycan

                                    Induced Arthritis” Selected as Top 25 of Basic Science Abstracts chosen from 3,508 Abstracts EULAR

                                    Congress Rome

2009                            Teaching Award for Excellence in Clinical Teaching, Dep. of Paediatrics, VUmc Amsterdam

2002                            Resident Teaching Award for Excellence in Clinical Teaching, Dep. of Paediatrics,

                                    Deventer Hospitals, NL

Research Output (109)

Prevalence of familial autoimmune diseases in juvenile idiopathic arthritis:results from the international Pharmachild registry

van Straalen Joeri W., de Roock Sytze, Giancane Gabriella, Alexeeva Ekaterina, Koskova Elena, Mesa-del-Castillo Bermejo Pablo, Zulian Francesco, Civino Adele, Montin Davide, Wulffraat Nico M., Ruperto Nicolino, Swart Joost F., 18 Nov 2022, In: Pediatric rheumatology online journal. 20

Real-world comparison of the effects of etanercept and adalimumab on well-being in non-systemic juvenile idiopathic arthritis:a propensity score matched cohort study

van Straalen Joeri W., de Roock Sytze, Giancane Gabriella, Consolaro Alessandro, Rygg Marite, Nordal Ellen B., Rubio-Pérez Nadina, Jelusic Marija, De Inocencio Jaime, Vojinovic Jelena, Wulffraat Nico M., Bruijning-Verhagen Patricia C.J., Ruperto Nicolino, Swart Joost F., Pallotti Chiara, Scala Silvia, Angioloni Simona, Villa Luca, 14 Nov 2022, In: Pediatric rheumatology online journal. 20

Factors associated with care- and health-related quality of life of caregivers of children with juvenile idiopathic arthritis

Grazziotin Luiza R., Currie Gillian, Twilt Marinka, IJzerman Maarten J., Kip Michelle M.A., Koffijberg Hendrik, Bonsel Gouke, Benseler Susanne M., Swart Joost F., Vastert Sebastiaan J., Wulffraat Nico M., Yeung Rae S.M., Armbrust Wineke, van den Berg J. Merlijn, Marshall Deborah A. 23 Jul 2022, In: Pediatric rheumatology online journal. 20 , p. 1-12

A diagnostic prediction model for separating juvenile idiopathic arthritis and chronic musculoskeletal pain syndrome

van Straalen Joeri W, van Stigt Thans Martine, Wulffraat Nico M, de Roock Sytze, Swart Joost F 20 Apr 2022, In: The Journal of Pediatrics. 251 , p. 164-171.e6

Real-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis:an observational study

Grazziotin Luiza R., Currie Gillian, Twilt Marinka, Ijzerman Maarten J., Kip Michelle M.A., Koffijberg Hendrik, Benseler Susanne M., Swart Joost F., Vastert Sebastiaan J., Wulffraat Nico M., Yeung Rae S.M., Marshall Deborah A. 11 Apr 2022, In: Pediatric rheumatology online journal. 20 , p. 1-11

Case Report:Lessons Learned From Subsequent Autologous and Allogeneic Hematopoietic Stem Cell Transplantations in a Pediatric Patient With Relapsing Polychondritis

Veldkamp Saskia R., Jansen Marc H.A., Swart Joost F., Lindemans Caroline A. 10 Mar 2022, In: Frontiers in Immunology. 13

Nailfold capillary scleroderma pattern may be associated with disease damage in childhood-onset systemic lupus erythematosus:important lessons from longitudinal follow-up

Schonenberg-Meinema Dieneke, Bergkamp Sandy C, Nassar-Sheikh Rashid Amara, Gruppen Mariken P, Middelkamp-Hup Maritza A, Armbrust Wineke, Dolman Koert, Hak A Elisabeth, Hissink Muller Petra C E, van Onna Marieke, Swart Joost F, Kuijpers Taco W, Kamphuis Sylvia S M, Smith Vanessa, van den Berg J Merlijn 9 Feb 2022, In: Lupus science & medicine. 9

Anakinra in Patients With Systemic Juvenile Idiopathic Arthritis:Long-term Safety From the Pharmachild Registry

Giancane Gabriella, Papa Riccardo, Vastert Sebastiaan, Bagnasco Francesca, Swart Joost F., Quartier Pierre, Antón Jordi, Kamphuis Sylvia, Sanner Helga, Glerup Mia, De Benedetti Fabrizio, Tsitsami Elena, Remesal Agustin, Moreno Estefania, De Inocencio Jaime, Myrup Charlotte, Pallotti Chiara, Koné-Paut Isabelle, Franck-Larsson Karin, Malmström Håkan, Cederholm Susanna, Pistorio Angela, Wulffraat Nico, Ruperto Nicolino, 1 Feb 2022, In: Journal of Rheumatology. 49 , p. 398-407 10 p.

Perspectives of Pediatric Rheumatologists on Initiating and Tapering Biologics in Patients with Juvenile Idiopathic Arthritis:A Formative Qualitative Study

Currie Gillian R., Pham Tram, Twilt Marinka, IJzerman Maarten J., Hull Pauline M., Kip Michelle M.A., Benseler Susanne M., Hazlewood Glen S., Yeung Rae S.M., Wulffraat Nico M., Swart Joost F., Vastert Sebastian J., Marshall Deborah A. 2022, In: Patient-Patient centered outcomes research. 15 , p. 599-609 11 p.

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet